Company Overview
Nortech Systems Incorporated operates within the healthcare sector, specifically focusing on the medical devices industry where it provides engineering design and manufacturing solutions for electromedical devices, electromechanical systems, assemblies, and components. These services are delivered across a global footprint that includes the United States, Mexico, and China, offering a comprehensive range of value-added engineering, technical, manufacturing, and support services to its client base. The company's current scale is defined by a market capitalization of $32.96M and an annual revenue of $116.67M, supported by a workforce of 701 employees. These valuation and revenue figures indicate that Nortech Systems is a small-cap entity with a specialized operational scope, reflecting its position as a niche provider rather than a large-scale diversified manufacturer.
Financial Health
The company reported a revenue of $116.67M for the trailing twelve months, while net income stood at $-2,627,000 and EBITDA was $741,000. The substantial gap between positive EBITDA and negative net income reveals a cost structure where significant non-operating expenses or interest costs are consuming the operating profits generated from core business activities. Free cash flow for the period was $-786,875, which indicates that the company is currently utilizing its cash reserves to fund operations or capital expenditures, thereby limiting immediate financial flexibility for discretionary spending or major acquisitions. The gross margin sits at 13.5%, suggesting that the cost of goods sold consumes a significant portion of sales revenue, typical for engineering-intensive manufacturing models. Operating margins are further compressed to 3.1%, while the profit margin turns negative at -2.3%, highlighting the pressure on profitability before considering non-operating items. On the balance sheet, the company holds $1.27M in cash against $21.10M in debt, resulting in a debt-to-equity ratio of 63.24, which characterizes the balance sheet as highly leveraged and reliant on external financing. Liquidity is maintained with a current ratio of 1.76, indicating that the company possesses sufficient current assets to cover its short-term liabilities, though the margin is not excessively wide. Return on Equity is -7.6% and return on assets is -0.5%, metrics that reveal that management has not yet generated positive returns on the capital invested by shareholders or the asset base, a common challenge during periods of expansion or restructuring.
Valuation Assessment
The trailing P/E ratio is N/A and the forward P/E is also N/A, implying that traditional earnings-based valuation multiples are not applicable due to the current lack of positive net income. The price-to-book ratio is 1.00, which indicates that the market values the company at par with its net book value, suggesting no significant premium or discount relative to the underlying asset base. Alternative valuation metrics provide further context, with a price-to-sales ratio of 0.28 and an EV/EBITDA of 64.20, suggesting that the market is pricing the company based on revenue multiples and enterprise value relative to operating cash flow rather than pure earnings. The stock has traded between a 52-week high of $12.40 and a 52-week low of $6.50, and based on the available data points, the price is currently positioned within this historical range, reflecting moderate volatility. The beta value is 0.04, which signifies that the stock price exhibits extremely low volatility relative to the broader market, moving independently of general market trends.
Growth & Income
Revenue growth year-over-year was -2.9%, while earnings growth is N/A due to the absence of positive earnings in the trailing twelve months. Because earnings are negative, the company is not currently generating growth in profitability that outpaces revenue contraction, and the negative earnings growth metric reflects the current financial performance rather than a trajectory of expansion. As a non-dividend payer, the company does not distribute a dividend yield or a payout ratio, meaning the 0.0% payout ratio reflects a strategy of retaining all cash flow for internal use rather than shareholder distributions. This absence of dividend payments aligns with the company's need to preserve capital given its negative free cash flow and leveraged balance sheet. The overall growth and income profile for Nortech Systems is characterized by revenue contraction in the most recent period and a lack of current profitability, with no income generated through dividends for investors holding the stock.